TTR and cardiac amyloidosis: Cardiac amyloidosis (CA), hereditary (h-ATTR-CA) or wild-type (wt-ATTR-CA), is the primary determinant of prognosis in patients with ATTR amyloidosis, with survival rates averaging 4–5 years after diagnosis [2].